Partner notification: do patients prefer patient or provider referral?

L J Tucker RGN, MA, V Harindra FRCP, J M Tobin FRCOG, MFFP,
Departments of Genitourinary Medicine, St Mary’s Hospital, Portsmouth

Key words: Partner notification, sexually transmitted infections, Genitourinary Medicine

Introduction
There has been a substantial rise in the diagnosis of acute sexually transmitted infections (STI) in the United Kingdom since 19951. Partner notification plays a central role in strategies to prevent the transmission of STIs and in their management 2. The main aims3 of partner notification are to identify and treat the sexual contact/s of patients diagnosed with a STI, prevent reinfection, reduce the pool of infection in the community and thereby decrease the incidence of infection and the complications associated with untreated STIs.
Three approaches to partner notification are used in the United Kingdom. In patient referral, when the index patient agrees to inform his or her sexual partner and where necessary, previous partners to attend a Genitourinary Medicine (GUM) department for clinical advice, assessment, diagnosis and treatment. In provider referral, the index patient asks a healthcare professional to notify sexual partner/s whilst maintaining the patients confidentiality. In conditional referral, the health care worker obtains information about the index patient’s sexual partners but an agreement is made to allow the index patient time to notify the partners first if possible4. There is little known about the current practice of partner notification in GUM clinics in England and Wales5. The aim of our study was to ascertain whether patients diagnosed with a STI prefer patient or provider referral for contacting their sexual partner/s.

Method
A prospective study was commenced in two GUM departments in December 2000 for a period of 6 weeks. A questionnaire was designed to determine the views of patients attending these two departments about partner notification. The healthcare worker completed the questionnaire during the partner notification phase of the consultation.
The self administered structured questionnaire consisted of seven questions to determine whether patients diagnosed with Chlamydia, gonorrhoea, non-gonococcal urethritis, genital herpes and genital warts would prefer to contact partner/s themselves (patient referral) or have assistance from GUM staff (provider referral). All patients diagnosed with these infections were asked to enrol in the study. Information was obtained as follows: - gender, sexuality, diagnosis, preference for patient or provider partner notification, number of traceable sexual partners seen within three months, area of partner’s residence and how many traceable sexual partners were seen and treated.

Results
Completed questionnaires were received from 80 partner notification consultations in clinic one (Portsmouth) an 80% response rate and 23 in clinic two (Isle of Wight) a 46% response rate. The age range for patients in clinic one was 16 to 55 years and in clinic two 14 to 50 years. In clinic one 74 (96%) of subjects were heterosexual and 6 (4%) homosexual in clinic two 21 (91%) heterosexual and 2 (7%) homosexual. In clinic one 80% (64) of patients were male and 16 (20%) female in clinic two 9 (39%) male and 14 (61%) female. Diagnoses are shown in table one.
In clinic one, 137 sexual contacts were identified, (range 1 to 8 partners per index patient). Forty-four (37%) sexual contacts were untraceable. In clinic two 28 sexual contacts were identified, (range 1 to 4 sexual partners per index patient). Two (7%) sexual contacts were untraceable. Partner outcome was known for 77 (83%) of traceable partners in clinic one and 15 (71%) in clinic two who were seen and treated. 75 (94%) of index patients in clinic one and 22 (96%) in clinic two preferred to contact their sexual partners themselves regardless of the index patients diagnosis, age, gender or sexuality.

Discussion
The most recent partner notification guidance was published in 19806. New guidelines are in progress. The majority of published studies report disease specific audits of the effectiveness of partner notification and treatment but do not describe current partner notification practice7. A recent survey of contact tracing for STIs in GUM clinics showed patient referral to be the most popular method.5
Interviews undertaken by NOP8 with a small number (17) of participants in the Department of Health (DoH) Chlamydia screening pilot study reported that subjects found notifying partners particularly problematic. Several respondents in the DoH Chlamydia pilot study said they would have preferred the staff in GUM to contact their ex partners rather than do this themselves. This has not been the experience of staff working in the Portsmouth and Isle of Wight GUM departments.
In this study the majority of patients (>93%) preferred to inform traceable sexual partners themselves of their diagnosis and subsequent need to attend a healthcare setting to obtain treatment and further management. The response rate to the survey was higher in clinic one than clinic two, a contributing factor may be because there were staffing problems in clinic two during the study period. Known outcome for traceable sexual partners was lower in clinic two; this may be because of the transient nature of people in the geographical area in which the clinic is situated. In addition there is a ‘close knit’ community on the IOW and therefore local people may choose to attend a GUM department anonymously on the mainland.
Unlike the Chlamydia screening pilot study8 this data and several other studies4,5,7 indicate that the vast majority of patients find patient referral both acceptable and effective and it is the preferred method of partner notification in the UK. A recently published study9 undertaken in central Africa indicates that patient referral of sexual contacts with a STI is highly acceptable and very effective at identifying and treating partners of people diagnosed with a STI. For patient referral techniques to be successful it is essential that the method is highly acceptable to patients and that all staff working in the GUM department are provided with appropriate training to ensure that they are able to discuss partner notification issues where relevant.

Table One: Patients diagnoses

         
         
         
         
         

References

  1. htttp://www.phls.co.uk/facts/STI/sti.htlm
  2. Steadman T (1998) Sexually Transmitted Infections, Nursing Care & Management; Stanley Thornes (Publishers) Ltd, Cheltenham UK.
  3. Sutton , A Payne, S (1996) Genitourinary Medicine for Nurses, Whurr, London.
  4. Millson ME, Rasooly I, Scott EAF, etal, Partner notification for sexually transmitted diseases: proposed practice guidelines. Can J Public Health 1994; suppl 1: S53-S55.
  5. Stokes, T, Schober P (1999) A survey for contact tracing practice for sexually transmitted diseases in GUM clinics in England and Wales; Int Journal of STD & AIDS; 10: 17-21.
  6. Hunter I, Jacobs J, Kinnell H, Satin A, (1980) A Handbook on Contact tracing in Sexually Transmitted Diseases. London: The Health Education Council.
  7. Cowan FM, French R, Johnson AM. (1996) The role and effectiveness of partner notification in STD control: a review. Genitourinary Medicine; 72: 247-252.
  8. Chlamydia pilot evaluation, Emerging Themes; NOP Consumer, Social & Political, Oral Presentation: DoH (2000).
  9. Koumans EH, Barker K,Massanga M,et.al (1999) Patient led partner referral enhances sexually transmitted disease service delivery in two towns in the Central African Republic. Int Journal of STD & AIDS; 10: 376-382.

Correspondence:
Mrs L J Tucker, Clinical Nurse Specialist, Department of Genitourinary Medicine, St Mary’s Hospital, Milton Road, Portsmouth, Hampshire, P03 6AD.
Acknowledgements:
Thank you to all the staff and patients at both departments who contributed to the data collection.

 



©2002 Sexual Health Matters. Published Quarterly by Express Print Works, Middlesbrough, UK
ISSN 1469-7556
http://www.sexualhealthmatters.com.